mardi 26 avril 2016

Onco Actu du 26 avril 2016

3.1 Tabac

Chantix smoking-cessation pill does not increase risk of suicide: study [STAT]

4.2 Dép., diag. & prono. - Génome

Everything you really need to know about DNA sequencing - Cancer Research UK - Science blog

5.10 Traitements - Essais

Childhood Leukemia Relapse Rates Improve with High Doses of Chemotherapy Drug Methotrexate [NYU Langone Medical Center]

5.12 Immunothérapies

Targeted Photoimmunotherapy for Cancer [National Cancer Institute]

5.2 Pharma

Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [BMS]

5.2.3 Pharma - économie

Supreme Court skeptical in case backed by drug makers [STAT]

5.3.4 Traitements - AMM (FDA, EMA)

Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy [Exelixis]

5.4 Traitements - Economie

Germany Is New Battlefield for Drugmakers Facing Price Scrutiny [Bloomberg]

5.9 AACR

Vice President Joe Biden Speaks at the AACR Annual Meeting 2016 [CANCER RESEARCH Catalyst]

6. Lutte contre les cancers

Ovarian Cancers: Evolving Paradigms in Research and Care [The National Academies Press]

6.1 Observation

30 years since Chernobyl and 5 years since Fukushima – What have we learnt? [Cancer Research UK]

6.6 Publications

You Pay to Read Research You Fund. That’s Ludicrous [WIRED]

6.8 Communication

Should science only be reported by journalists with a scientific background? [The Institute of Cancer Research]